Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus

Autor: Nieminen, M.S., Altenberger, J., Ben-Gal, T., Böhmer, A., Comin-Colet, J., Dickstein, K., Édes, I., Fedele, F., Fonseca, C., García-González, M.J., Giannakoulas, G., Iakobishvili, Z., Jääskeläinen, P., Karavidas, A., Kettner, J., Kivikko, M., Lund, L.H., Matskeplishvili, S.T., Metra, M., Morandi, F., Oliva, F., Parkhomenko, A., Parissis, J., Pollesello, P., Pölzl, G., Schwinger, R.H.G., Segovia, J., Seidel, M., Vrtovec, B., Wikström, G.

Publikováno v: In International Journal of Cardiology 15 June 2014 174(2):360-367

Relation of inflammation to vascular function in patients with coronary heart disease

Autor: Sinisalo, J ^*, Paronen, J, Mattila, K.J, Syrjälä, M, Alfthan, G, Palosuo, T, Nieminen, M.S, Vaarala, O

Publikováno v: In Atherosclerosis 2000 149(2):403-411

Clinical picture and risk prediction of short-term mortality in cardiogenic shock

Autor: Harjola V.-P., Lassus J., Sionis A., Køber L., Tarvasmäki T., Spinar J., Parissis J., Banaszewski M., Silva-Cardoso J., Carubelli V., Di Somma S., Tolppanen H., Zeymer U., Thiele H., Nieminen M.S., Mebazaa A.

Publikováno v: EUROPEAN JOURNAL OF HEART FAILURE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Aims The aim of this study was to investigate the clinical picture and outcome of cardiogenic shock and to develop a risk prediction score for short-term mortality. Methods and results The CardShock study was a multicentre, prospective, observational

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4167ad5fab3f75d49a613d93d21dfd56
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=10375

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Levosimendan: current data, clinical use and future development

Autor: Nieminen, M.S., Fruhwald, S., Heunks, L.M.A., Suominen, P.K., Gordon, A.C., Kivikko, M., Pollesello, P.

Publikováno v: Heart, Lung and Vessels, 5, 4, pp. 227-245
Heart, Lung and Vessels
Heart, Lung and Vessels, 5, 227-245

Item does not contain fulltext Levosimendan is an inodilator indicated for the short-term treatment of acutely decompensated severe chronic heart failure, and in situations where conventional therapy is not considered adequate. The principal pharmaco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a86d64beaaf8eb0131662984df50a7f2
http://hdl.handle.net/10044/1/12898